New Paradigm Capital Management »

SPDR S&P Biotech shares owned by New Paradigm Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by New Paradigm Capital Management from 13F filings

Historical chart of New Paradigm Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by New Paradigm Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by New Paradigm Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 9.0k 158.25

More positions owned by New Paradigm Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Goldman Sachs (GS)
Eli Lilly & Co. (LLY)
Seagate Technology Hldngs Pl Ord Shs (STX)
Intel Corporation (INTC)
Cisco Systems (CSCO)
Applied Materials (AMAT)
Ge Vernova (GEV)
Ge Aerospace Com New (GE)
Spdr Series Trust St Str Sp Biot (XBI)
Kla Corp Com New (KLAC)
Teradyne (TER)
Ishares Tr Ishares Biotech (IBB)
Ishares Tr Ishares Semicdtr (SOXX)
Micron Technology (MU)

View all positions for New Paradigm Capital Management

Top funds holding SPDR S&P Biotech

Bnp Paribas Arbitrage, Snc
Bank of America Corporation
Goldman Sachs Group
Morgan Stanley
Citigroup
Deep Track Capital
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Jane Street
Citadel Advisors
UBS Group
Barclays
Wells Fargo & Company
Leucadia National Corporation
Jain Global

View all funds holding SPDR S&P Biotech